ArticleEpilepsia2026
Does stereoelectroencephalographic depth electrode insertion alter seizure frequency? A baseline versus endpoint analysis.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The implantation effect refers to a transient reduction in seizure frequency following intracranial electrode insertion in patients with epilepsy, independent of therapeutic intervention. This retrospective study examined potential clinical and demographic predictors of the implantation effect in 51 patients who underwent stereoelectroencephalographic investigation between December 2018 and February 2020. Follow-up data were collected at 1, 3, 6, and 12 months postimplantation. A ≥50% reduction in seizure frequency defined responder status. Responder rates were 71.4% at 1 month, 35.0% at 3 months, 33.3% at 6 months, and 50.0% at 12 months. Complete seizure freedom was observed in 42.9% of patients at 1 month and 20.0% at 3 months. No significant associations were found between seizure reduction and age, sex, imaging findings, cortical stimulation, electrode count, or preimplantation antiseizure medication type or load. The lack of predictive variables, alongside seizure reduction in patients with previously uncontrolled epilepsy, supports the hypothesis that electrode-induced microlesions may transiently disrupt epileptogenic networks. The quantity of electrodes did not influence outcomes, suggesting that implantation location may be more important. The effects of antiseizure medications remain unclear due to limited tracking of dosage or regimen changes. Further prospective research is needed to clarify the mechanisms underlying the implantation effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.